UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Crestwood Advisors Group LLC

Crestwood Advisors Group LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,147 shares of the healthcare conglomerate’s stock after acquiring an additional 269 shares during the period. Crestwood Advisors Group LLC’s holdings in UnitedHealth Group were worth $2,098,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of UNH. IFP Advisors Inc increased its holdings in shares of UnitedHealth Group by 2.6% in the fourth quarter. IFP Advisors Inc now owns 16,227 shares of the healthcare conglomerate’s stock valued at $8,211,000 after buying an additional 413 shares in the last quarter. WealthShield Partners LLC lifted its holdings in shares of UnitedHealth Group by 1.7% during the fourth quarter. WealthShield Partners LLC now owns 7,788 shares of the healthcare conglomerate’s stock valued at $3,939,000 after purchasing an additional 129 shares during the last quarter. Hardman Johnston Global Advisors LLC increased its stake in UnitedHealth Group by 13.0% in the 4th quarter. Hardman Johnston Global Advisors LLC now owns 71,871 shares of the healthcare conglomerate’s stock worth $36,357,000 after purchasing an additional 8,289 shares in the last quarter. Conscious Wealth Investments LLC lifted its stake in UnitedHealth Group by 4.4% during the fourth quarter. Conscious Wealth Investments LLC now owns 5,507 shares of the healthcare conglomerate’s stock valued at $2,807,000 after buying an additional 232 shares in the last quarter. Finally, Cherry Tree Wealth Management LLC increased its position in shares of UnitedHealth Group by 6.9% in the fourth quarter. Cherry Tree Wealth Management LLC now owns 871 shares of the healthcare conglomerate’s stock worth $440,000 after acquiring an additional 56 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on UNH shares. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

NYSE UNH opened at $461.09 on Tuesday. The company has a market cap of $424.33 billion, a P/E ratio of 29.75, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a fifty day simple moving average of $518.52 and a 200 day simple moving average of $559.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.82%. UnitedHealth Group’s payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.